Education
About Us
Working with TipRanks
Follow Us
MediPharm Labs (MEDIF)
OTHER OTC:MEDIF
Earnings Data
Report Date
Aug 18, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0Last Year’s EPS
>-0.01Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 14, 2025
|% Change Since: -14.29%
|Next Earnings Date:Aug 18, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted significant improvements in financial performance with record gross profit margins, positive adjusted EBITDA, and strong international revenue growth. However, challenges remain in the Canadian market, and there is an ongoing dispute with an activist shareholder. The overall sentiment is optimistic about continued growth and stability.Company Guidance
During the MediPharm Labs Conference Call discussing the first quarter of fiscal year 2025 results, the company highlighted significant improvements across key financial metrics. Gross profit for Q1 2025 was CAD 4.2 million, representing a gross margin of 38.7% of sales, marking the highest gross margin achieved in many years. This is a notable improvement from past negative gross margins. Additionally, adjusted EBITDA turned positive at CAD 141,000, a substantial improvement from a CAD 949,000 loss in the prior year. The international segment now accounts for over 50% of total revenues, with international medical cannabis revenue increasing by 87% year-over-year to CAD 5.9 million. Operating expenses for the quarter decreased significantly, with general and administrative expenses down by 29% compared to the previous year. MediPharm's strong balance sheet, with a cash balance of CAD 8.4 million and virtually no debt, supports its ability to invest in growth opportunities and positions the company as a reliable partner in the international markets. The company's strategic focus on improving margins, lowering operating costs, and expanding its international presence has been instrumental in its financial turnaround.Record Gross Profit and Margin
MediPharm achieved a gross profit of CAD4.2 million, representing 38.7% of sales, marking the highest gross margin in many years. This is a significant improvement from previous negative margins.
Positive Adjusted EBITDA
For the first time in over five years, MediPharm reported a positive adjusted EBITDA of CAD141,000, showing a substantial improvement from a CAD6 million negative EBITDA in 2022.
International Revenue Surge
International medical cannabis revenue increased by 87% year-over-year to CAD5.9 million, now accounting for over 50% of total revenues.
Balance Sheet Strength
MediPharm has a strong cash position of CAD8.4 million, virtually no debt, and owns all its facilities outright, positioning it well for future growth opportunities.
Successful Integration of VIVO
The acquisition of VIVO has been fully integrated and is contributing to the company's growth, particularly in international markets like Germany and Australia.
---
MEDIF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MEDIF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2025 | $0.07 | $0.08 | +14.29% |
Mar 31, 2025 | $0.07 | $0.07 | 0.00% |
Nov 14, 2024 | $0.05 | $0.05 | 0.00% |
Aug 14, 2024 | $0.05 | $0.05 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does MediPharm Labs (MEDIF) report earnings?
MediPharm Labs (MEDIF) is schdueled to report earning on Aug 18, 2025, TBA Not Confirmed.
What is MediPharm Labs (MEDIF) earnings time?
MediPharm Labs (MEDIF) earnings time is at Aug 18, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MEDIF EPS forecast?
MEDIF EPS forecast for the fiscal quarter 2025 (Q2) is 0.
---